Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) 관련 Age-Related Cognitive Decline

A

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs: None Outcome: Neurological health outcomes 효과: None None

대상 집단: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD 효과: None None

대상 집단: Alzheimer's disease patients

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None vs: None Outcome: Age-dependent brain lipid changes 효과: None None

대상 집단: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Key Statistics

58

연구

12000

참여자

Positive

A

등급

Referenced Papers

Molecules (Basel, Switzerland) 2025 10 인용
Journal of Alzheimer's … 2025 3 인용
Nutrients 2025 2 인용
Current opinion in … 2023 58 인용
Nutrients 2022 76 인용
International journal of … 2022 23 인용
Current nutrition reports 2019 310 인용
Nutricion hospitalaria 2019 40 인용
American family physician 2018 101 인용
Nutricion hospitalaria 2018 32 인용
Advances in nutrition … 2013 155 인용
Current treatment options … 2011 6 인용
Molecular neurobiology 2010 145 인용
Women's health (London, … 2010 48 인용
The Practitioner 2010
The Cochrane database … 2009 299 인용
Prostaglandins, leukotrienes, and … 2009 258 인용
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 인용
Prostaglandins, leukotrienes, and … 2006 176 인용
Medecine sciences : … 2005 19 인용
The Cochrane database … 2003 263 인용
Journal of Alzheimer's … 2003 161 인용
Pharmacological research 1999 1060 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

상한량: 3,000 mg/day combined DHA/EPA (FDA GRAS)

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --

권장 복용 시간: With meals containing fat for better absorption

Safety & Side Effects

보고된 부작용

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

알려진 상호작용

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

일일 최대 섭취 허용량: 3,000 mg/day combined DHA/EPA (FDA GRAS)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support Age-Related Cognitive Decline management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.